Gene Set Name

# Genes in Gene Set (K)

# Genes in Overlap (k)

k/K

p-value

FDR q-value

KEGG_PATHWAYS_IN_CANCER

328

33

0.101

8.64E-09

1.61E-06

KEGG_JAK_STAT_SIGNALING_PATHWAY

155

17

0.110

1.08E-05

1.00E-03

KEGG_INSULIN_SIGNALING_PATHWAY

137

15

0.110

3.56E-05

1.76E-03

KEGG_DILATED_CARDIOMYOPATHY

92

12

0.130

3.78E-05

1.76E-03

KEGG_MAPK_SIGNALING_PATHWAY

267

22

0.082

5.72E-05

2.13E-03

KEGG_AXON_GUIDANCE

129

14

0.109

7.06E-05

2.19E-03

KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM

85

11

0.129

8.49E-05

2.25E-03

KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION

118

13

0.110

1.09E-04

2.53E-03

KEGG_OLFACTORY_TRANSDUCTION

389

27

0.069

1.66E-04

3.44E-03

KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION

272

21

0.077

2.06E-04

3.84E-03

KEGG_CARDIAC_MUSCLE_CONTRACTION

80

10

0.125

2.36E-04

3.99E-03

KEGG_WNT_SIGNALING_PATHWAY

151

14

0.093

3.74E-04

5.14E-03

KEGG_TIGHT_JUNCTION

134

13

0.097

3.86E-04

5.14E-03

KEGG_PANCREATIC_CANCER

70

9

0.129

3.87E-04

5.14E-03

KEGG_NUCLEOTIDE_EXCISION_REPAIR

44

7

0.159

4.61E-04

5.56E-03

KEGG_LEISHMANIA_INFECTION

72

9

0.125

4.78E-04

5.56E-03

KEGG_VIRAL_MYOCARDITIS

73

9

0.123

5.30E-04

5.80E-03

KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY

108

11

0.102

7.05E-04

6.84E-03

KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC

76

9

0.118

7.15E-04

6.84E-03

KEGG_GLYCOLYSIS_GLUCONEOGENESIS

62

8

0.129

7.88E-04

6.84E-03

KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION

48

7

0.146

7.93E-04

6.84E-03

KEGG_FOCAL_ADHESION

201

16

0.080

8.09E-04

6.84E-03

KEGG_CELL_ADHESION_MOLECULES_CAMS

134

12

0.090

1.29E-03

1.04E-02

KEGG_P53_SIGNALING_PATHWAY

69

8

0.116

1.60E-03

1.11E-02

KEGG_PYRUVATE_METABOLISM

40

6

0.150

1.61E-03

1.11E-02

KEGG_MELANOGENESIS

102

10

0.098

1.62E-03

1.11E-02

KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS

138

12

0.087

1.66E-03

1.11E-02

KEGG_REGULATION_OF_ACTIN_CYTOSKELETON

216

16

0.074

1.72E-03

1.11E-02

KEGG_TGF_BETA_SIGNALING_PATHWAY

86

9

0.105

1.74E-03

1.11E-02

KEGG_BASAL_CELL_CARCINOMA

55

7

0.127

1.80E-03

1.12E-02

KEGG_ASTHMA

30

5

0.167

2.44E-03

1.45E-02

KEGG_LYSINE_DEGRADATION

44

6

0.136

2.65E-03

1.45E-02

KEGG_HUNTINGTONS_DISEASE

185

14

0.076

2.67E-03

1.45E-02

KEGG_ADHERENS_JUNCTION

75

8

0.107

2.73E-03

1.45E-02

KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY

75

8

0.107

2.73E-03

1.45E-02

KEGG_ACUTE_MYELOID_LEUKEMIA

60

7

0.117

2.99E-03

1.54E-02

KEGG_CITRATE_CYCLE_TCA_CYCLE

32

5

0.1562

3.27E-03

1.65E-02

KEGG_COLORECTAL_CANCER

62

7

0.1129

3.60E-03

1.76E-02

KEGG_BASE_EXCISION_REPAIR

35

5

0.1429

4.87E-03

2.32E-02

KEGG_PURINE_METABOLISM

159

12

0.0755

5.30E-03

2.47E-02

KEGG_SMALL_CELL_LUNG_CANCER

84

8

0.0952

5.50E-03

2.49E-02

KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION

23

4

0.1739

5.69E-03

2.52E-02

KEGG_ENDOMETRIAL_CANCER

52

6

0.1154

6.17E-03

2.67E-02

KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450

70

7

0.1

7.04E-03

2.98E-02

KEGG_NON_SMALL_CELL_LUNG_CANCER

54

6

0.1111

7.42E-03

3.07E-02

KEGG_DRUG_METABOLISM_CYTOCHROME_P450

72

7

0.0972

8.20E-03

3.27E-02

KEGG_CELL_CYCLE

128

10

0.0781

8.26E-03

3.27E-02

KEGG_GALACTOSE_METABOLISM

26

4

0.1538

8.91E-03

3.38E-02

KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE

26

4

0.1538

8.91E-03

3.38E-02

KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM

76

7

0.0921

1.09E-02

4.06E-02